VMP 18291211000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Sevelamer 800mg tablets
BNF code 0905022S0AAABAB
Virtual Therapeutic Moiety Sevelamer
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Sevelamer
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 800.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Renagel 800mg tablets (CST Pharma Ltd)
Renagel 800mg tablets (Originalis B.V.)
Renagel 800mg tablets (Sanofi)
Renvela 800mg tablets (CST Pharma Ltd)
Renvela 800mg tablets (DE Pharmaceuticals)
Renvela 800mg tablets (Originalis B.V.)
Renvela 800mg tablets (Sanofi)
Sevelamer 800mg tablets (A A H Pharmaceuticals Ltd)
Sevelamer 800mg tablets (Alliance Healthcare (Distribution) Ltd)
Sevelamer 800mg tablets (Consilient Health Ltd)
Sevelamer 800mg tablets (DE Pharmaceuticals)
Sevelamer 800mg tablets (Medihealth (Northern) Ltd)
Sevelamer 800mg tablets (Sovereign Medical Ltd)
Sevelamer 800mg tablets (Viatris UK Healthcare Ltd)
Sevelamer 800mg tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Sevelamer 800mg tablets 180 tablet

dm+d data retrieved from TRUD: release NHSBSA_1.3.0_20230123000001, imported on 25th January 2023 at 03:52:49.